RESMED INC — Director's Dealing 2017

Aug 23, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-22

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-22	ResMed Common Stock	G	6757	$74.17	Disposed	294800	Direct

Footnotes

F1: Represents a gift to the Scripps Research Institute, a 501(c)(3) non-profit corporation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.

F2: This transaction was executed in multiple trades at prices ranging from 73.49 to 74.85. The price reported above represents the weighted average sales price.